Per‐ and polyfluoroalkyl substances (PFAS) are ubiquitous environmental contaminants associated with adverse reproductive outcomes including reproductive cancers in women. PFAS can alter normal ovarian function, but the effects of PFAS on ovarian cancer progression and therapy response remain understudied. Ovarian cancer is the most lethal gynecologic malignancy, and a major barrier to effective treatment is resistance to platinum‐based chemotherapy. Platinum resistance may arise from exposure to external stimuli such as environmental contaminants. This study evaluated PFAS and PFAS mixture exposures to two human ovarian cancer cell lines to evaluate the ability of PFAS exposure to affect survival fraction following treatment with carboplatin. This is the first study to demonstrate that, at sub‐cytotoxic concentrations, select PFAS and PFAS mixtures increased survival fraction in ovarian cancer cells following carboplatin treatment, indic-ative of platinum resistance. A concomitant increase in mitochondrial membrane potential, meas-ured by the JC‐1 fluorescent probe, was observed in PFAS‐exposed and PFAS + carboplatin‐treated cells, suggesting a potential role for altered mitochondrial function that requires further investiga-tion.
CITATION STYLE
Rickard, B. P., Tan, X., Fenton, S. E., & Rizvi, I. (2022). Select Per‐ and Polyfluoroalkyl Substances (PFAS) Induce Resistance to Carboplatin in Ovarian Cancer Cell Lines. International Journal of Molecular Sciences, 23(9). https://doi.org/10.3390/ijms23095176
Mendeley helps you to discover research relevant for your work.